Spots Global Cancer Trial Database for mistletoe extract
Every month we try and update this database with for mistletoe extract cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients | NCT01401075 | Gastric Cancer | mistletoe extra... doxifluridine | 19 Years - 70 Years | Abnoba Gmbh | |
Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy | NCT00052325 | Lung Cancer | mistletoe extra... | 18 Years - | National Cancer Institute (NCI) | |
Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy | NCT00052325 | Lung Cancer | mistletoe extra... | 18 Years - | National Cancer Institute (NCI) | |
Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | NCT00006354 | Unspecified Adu... | mistletoe extra... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer | NCT02007005 | Superficial Bla... | abnobaVISCUM Fr... | 18 Years - 80 Years | Abnoba Gmbh | |
Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors | NCT00006477 | Unspecified Adu... | mistletoe extra... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. | NCT00516022 | Non Small Cell ... | Mistletoe extra... | 18 Years - | Rambam Health Care Campus | |
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors | NCT06408688 | Advanced Solid ... | Immune checkpoi... Immune Checkpoi... | 18 Years - | University Hospital, Basel, Switzerland | |
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients | NCT01401075 | Gastric Cancer | mistletoe extra... doxifluridine | 19 Years - 70 Years | Abnoba Gmbh | |
Therapeutic Instillation of Mistletoe | NCT02106572 | Superficial Bla... | abnobaVISCUM 90... Mitomycin C | 18 Years - 85 Years | Abnoba Gmbh | |
Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. | NCT00516022 | Non Small Cell ... | Mistletoe extra... | 18 Years - | Rambam Health Care Campus | |
Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | NCT00006354 | Unspecified Adu... | mistletoe extra... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors | NCT00049608 | Breast Cancer Colorectal Canc... Lung Cancer Pancreatic Canc... | mistletoe extra... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer | NCT02007005 | Superficial Bla... | abnobaVISCUM Fr... | 18 Years - 80 Years | Abnoba Gmbh | |
Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. | NCT00516022 | Non Small Cell ... | Mistletoe extra... | 18 Years - | Rambam Health Care Campus |